NEW YORK--(BUSINESS WIRE)--Jan 3, 2023--

Bristol Myers Squibb (NYSE: BMY) today announced that the company will present at J.P. Morgan’s 41 st Annual Healthcare Conference on Monday, January 9, 2023. Giovanni Caforio, M.D., Board Chair and Chief Executive Officer will make a formal presentation and answer questions about the company at 7:30 a.m. PST/10:30 a.m. EST.

The event will be webcast simultaneously at http://investor.bms.com with materials related to the presentation available at the start of the live webcast. A replay and archived edition of the presentation will be available following the event.

About Bristol Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.

corporatefinancial-news

View source version on businesswire.com:https://www.businesswire.com/news/home/20230103005011/en/

CONTACT: Bristol Myers SquibbMedia:

media@bms.comInvestor Relations:

investor.relations@bms.com

KEYWORD: UNITED STATES NORTH AMERICA NEW YORK

INDUSTRY KEYWORD: HEALTH TECHNOLOGY OTHER PROFESSIONAL SERVICES OTHER HEALTH PHARMACEUTICAL PROFESSIONAL SERVICES GENERAL HEALTH MEDICAL DEVICES FITNESS & NUTRITION CLINICAL TRIALS SCIENCE BIOTECHNOLOGY OTHER SCIENCE HEALTH RESEARCH MEDICAL SUPPLIES

SOURCE: Bristol Myers Squibb

Copyright Business Wire 2023.

PUB: 01/03/2023 07:05 AM/DISC: 01/03/2023 07:05 AM

http://www.businesswire.com/news/home/20230103005011/en